Integer Holdings Corporation · NYSE:ITGR
Integer — Piper Jaffray Conference 2019
12 slides from Integer's conference presentation, Dec 5, 2019
Slide 1: Piper Jaffray Conference Presentation
Piper Jaffray Conference Presentation December 5, 2019
Slide 2: Presentation of Financial Information & Forward-Looking Statements
Presentation of Financial Information & Forward-Looking Statements Historical financial and operating data in this presentation reflect the consolidated results of Integer for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles ge
Slide 3: Revenue by Markets Served - $1.26 billion
Revenue by Markets Served - $1.26 billion(1) Markets Markets Tachycardia Cardiovascular / Urology Bradycardia Structural Heart SCS / Neurostimulation Oncology Cardiac Rhythm Peripheral Vascular Management & Products Neuromodulation Electrophysiology 37% Neurovascular Leads & Lead Components, Feedthr
Slide 4: Focused Strategy to Drive Long-term Growth
Focused Strategy to Drive Long-term Growth Portfolio Strategy Operational Strategy: How we win Strategic Imperatives in the markets we serve How we achieve excellence in everything we do Invest to Grow Cardio & Vascular Neuromodulation Electrochem Portable Medical Protect & Preserve Cardiac Rhythm M
Slide 5: Executive Alignment to Drive Our Strategy
Executive Alignment to Drive Our Strategy Portfolio Strategy Operational Strategy Product Category Leaders Strategic Imperative Leaders Market Focused Sales Force Innovation Excellence Payman Khales President, Cardio & Vascular Manufacturing Excellence Payman Khales Joel Becker President, C&V Presid
Slide 6: Product Line Strategy and Growth Teams
Product Line Strategy and Growth Teams Integer’s Sustainable Process to Drive Growth Product Integer’s Product Line Strategy Process is how we develop winning strategies for Line Product Lines in our portfolio. Product Line Strategies include standard processes, Strategies tools and governance that
Slide 7: Manufacturing Excellence: Business Optimization and Margin Expansion
Manufacturing Excellence: Business Optimization and Margin Expansion Status • Defined & scoped 16 elements that Integer • Framework and detailed system comprise the IPS Production elements of our Integer Systems manufacturing processes • IPS element tools, templates and resources in process • All 15
Slide 8: 2019 Full-Year Outlook
2019 Full-Year Outlook Adjusted Sales Adjusted EBITDA Adjusted EPS Growth % 3% - 4.5% 9% - 10% 20% - 22% $1,253 - $1,268 $282 - $286 $4.55 - $4.65 $1,213 $259 $3.80 Original Guidance $1,260 - $1,280 $275 - $283 $4.05 - $4.25 8 ITGR: Investor Presentation / November 2019 ($ in millions except per sha
Slide 9: 2019 Cash Flow Outlook
2019 Cash Flow Outlook ($ in millions) Cash Flow From Ops Free Cash Flow(1) Debt Payments Leverage(2) $700 No change, $548 despite $15 million $160 - $170 acquisition $110 - $120 Target $105 - $115 2.5x - 3.5x ~2.9x $67 - $77 Divestiture Proceeds Accelerated Repayment Required Repayment Original $16
Slide 10: Balanced & Disciplined Capital Allocation
Balanced & Disciplined Capital Allocation Leverage framework ü Continued EBITDA growth Sig del nifica ü Increased free cash flow eve n rag t 6.1x ing ü Capacity for “bolt-on” acquisitions Debt x 5.6x ü Recently amended credit facility EBITDA reducing interest expense Leverage 3.5x 2.9x ~2.5 - 3.5x 2
Slide 11: Integer's Journey – Executing Long-term Growth Strategy
Integer’s Journey – Executing Long-term Growth Strategy Revenue Growth versus Prior Year: 2015 2016 2017 2018 2019 Guidance Strategic Objectives 2015 2016 2017 2018 2021 7% 3% - 4.5% Market + 2% 5% (2)% (4)% • Market growth, ex Nuvectra • 200bps above market Declined • Market growth • 2x revenue gro
Slide 12: Contact Information
Contact Information Tony Borowicz SVP, Strategy, Corporate Development & Investor Relations Integer Tony.Borowicz@Integer.net (O) 716.759.5809 www.integer.net 12 ITGR: Investor Presentation / November 2019